Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mechanisms for tolerance to methamphetamine effects

M P Gygi1, S P Gygi, M Johnson

  • 1Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, USA.

Neuropharmacology
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of low-frequency operational limit of proposed ITER low-field-side reflectometer waveguide run including miter bends.

The Review of scientific instruments·2017
Same author

Commonly Practiced Quality Control and Quality Assurance Procedures for Gas Chromatography-Mass Spectrometry Analysis in Forensic Urine Drug-Testing Laboratories.

Forensic science review·2015
Same author

Testing for Drugs of Abuse in Hair - Experimental Observations and Indications for Future Research.

Forensic science review·2015
Same author

Using X-mode L, R and O-mode reflectometry cutoffs to measure scrape-off-layer density profiles for upgraded ORNL reflectometer on NSTX-U.

The Review of scientific instruments·2014
Same author

Response of limbic neurotensin systems to methamphetamine self-administration.

Neuroscience·2012
Same author

Optimization studies of the ITER low field side reflectometer.

The Review of scientific instruments·2010
Same journal

Purinergic-cytokine signaling as a regulatory axis in neuroimmune development.

Neuropharmacology·2026
Same journal

Acupuncture Improves Depressive Symptoms and Prefrontal Cortical Function in Mild to Moderate Depressive Disorder: A Randomized Sham-Controlled Trial and fNIRS study.

Neuropharmacology·2026
Same journal

A staged zebrafish-mouse screening strategy for antiseizure compound prioritization.

Neuropharmacology·2026
Same journal

DNMT3a-mediated GluN2B desilencing in the anterior cingulate cortex underlies chemotherapy-induced neuropathic pain.

Neuropharmacology·2026
Same journal

Resveratrol alleviates neurological disorders and motor dysfunction in 3-NP induced- Huntington's Disease in rats: Role of activating AMPK/SIRT1/ULK1 autophagy pathway.

Neuropharmacology·2026
Same journal

Repurposing Citicoline for single prolonged stress-induced behavioral and hippocampal molecular abnormalities in male mice: Novel mechanistic attenuation of endoplasmic reticulum stress, mitochondrial dysfunction, oxidative stress, and apoptosis.

Neuropharmacology·2026
See all related articles

Methamphetamine (MA) pretreatment induces tolerance to its own serotonergic effects. This tolerance involves altered MA distribution, with lower brain and higher plasma concentrations, suggesting an active transport mechanism.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Toxicology

Background:

  • Methamphetamine (MA) abuse is a significant public health concern.
  • Understanding the neurobiological mechanisms of MA tolerance is crucial for developing effective treatments.
  • MA tolerance is characterized by reduced physiological and behavioral responses to repeated drug administration.

Purpose of the Study:

  • To investigate the development of tolerance to the serotonergic effects of MA.
  • To examine the impact of MA tolerance on MA distribution in the brain and plasma.
  • To explore the role of active transport systems in MA distribution and tolerance.

Main Methods:

  • Rats were pretreated with incrementally increasing doses of MA to induce tolerance.
  • Serotonergic effects were assessed following a high-dose MA challenge.

Related Experiment Videos

  • Brain and plasma concentrations of MA were measured in tolerant and non-tolerant rats.
  • The effect of probenecid, a transport-blocking drug, on MA distribution and effects was investigated.

    • Main Results:

    • Incremental MA pretreatment led to tolerance in serotonergic systems.
    • Tolerant rats exhibited reduced brain MA concentrations and elevated plasma MA concentrations.
    • Tolerance was specific to MA and not observed with cocaine pretreatment.
    • Probenecid enhanced MA-induced serotonergic changes and increased brain MA concentrations, but this effect was distinct from tolerance-related redistribution.

    Conclusions:

    • MA tolerance involves altered drug distribution, potentially mediated by active transport.
    • The findings suggest that active transport systems play a role in regulating MA entry into and exit from the brain.
    • Further research into these transport mechanisms could inform therapeutic strategies for MA dependence.